Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
24,036
-
Share change
-
-2,488
-
Total reported value
-
$270,165
-
Price per share
-
$11.24
-
Number of holders
-
1
-
Value change
-
-$27,965
-
Number of sells
-
1
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2023
As of 31 Dec 2023,
Theravance Biopharma, Inc. - Common Stock (TBPH) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
24,036 shares.
The largest 10 holders included
Weiss Asset Management LP, BAUPOST GROUP LLC/MA, Madison Avenue Partners, LP, BlackRock Inc., VANGUARD GROUP INC, Irenic Capital Management LP, Pictet Asset Management Holding SA, Newtyn Management, LLC, STATE STREET CORP, and Oasis Management Co Ltd..
This page lists
116
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.